D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$751M |
| 2 |
Advanced Micro Devices
AMD
|
+$751M |
| 3 |
Micron Technology
MU
|
+$426M |
| 4 |
Chipotle Mexican Grill
CMG
|
+$363M |
| 5 |
ExxonMobil
XOM
|
+$356M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$546M |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$485M |
| 3 |
VMW
VMware, Inc
VMW
|
+$393M |
| 4 |
Microsoft
MSFT
|
+$336M |
| 5 |
UnitedHealth
UNH
|
+$303M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.03% |
| 2 | Consumer Discretionary | 9.51% |
| 3 | Healthcare | 5.76% |
| 4 | Financials | 5.47% |
| 5 | Communication Services | 4.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3601
Forrester Research
FORR
$172M
| $300K | ﹤0.01% |
+11,208
| New | +$292K |
|
|
CMPOW
3602
DELISTED
CompoSecure Inc Warrant
CMPOW
| $300K | ﹤0.01% |
804,924
+188,355
| +31% | +$96K |
|
3603
PUT
Amplify Energy
AMPY
$163M
| $297K | ﹤0.01% |
50,000
| – | – |
|
|
PLYM
3604
DELISTED
Plymouth Industrial REIT
PLYM
| $295K | ﹤0.01% |
12,258
-18,580
| -60% | -$404K |
|
|
THRD
3605
DELISTED
Third Harmonic Bio
THRD
| $294K | ﹤0.01% |
+26,761
| New | +$212K |
|
|
KREF
3606
KKR Real Estate Finance Trust
KREF
$472M
| $293K | ﹤0.01% |
+22,135
| New | +$265K |
|
3607
Silicom
SILC
$228M
| $292K | ﹤0.01% |
+16,148
| New | +$298K |
|
|
FIRY
3608
Firy Inc
FIRY
$127M
| $292K | ﹤0.01% |
46,725
-3,744
| -7% | -$20.9K |
|
3609
PUT
Kyndryl
KD
$2.66B
| $291K | ﹤0.01% |
14,000
| – | – |
|
3610
Ituran Location and Control
ITRN
$1.08B
| $290K | ﹤0.01% |
10,664
-4,755
| -31% | -$126K |
|
3611
Workhorse Group
WKHS
$29.5M
| $290K | ﹤0.01% |
269
+102
| +61% | +$122K |
|
3612
NNN REIT
NNN
$9.39B
| $290K | ﹤0.01% |
6,724
-267,202
| -98% | -$10.3M |
|
3613
iShares MSCI Brazil Small-Cap ETF
EWZS
$227M
| $289K | ﹤0.01% |
+19,192
| New | +$263K |
|
3614
PUT
Novavax
NVAX
$1.23B
| $288K | ﹤0.01% |
60,000
-52,500
| -47% | -$321K |
|
|
SVM
3615
Silvercorp Metals
SVM
$2.13B
| $287K | ﹤0.01% |
110,400
+34,500
| +45% | +$84.5K |
|
3616
CEL-SCI Corp
CVM
$20.6M
| $287K | ﹤0.01% |
3,519
+2,335
| +197% | +$145K |
|
3617
CALL
Goodyear
GT
$2.07B
| $286K | ﹤0.01% |
20,000
| – | – |
|
3618
Root
ROOT
$917M
| $285K | ﹤0.01% |
+27,204
| New | +$270K |
|
|
SUP
3619
DELISTED
Superior Industries International
SUP
| $285K | ﹤0.01% |
89,056
-64,821
| -42% | -$183K |
|
3620
iShares US Energy ETF
IYE
$1.74B
| $283K | ﹤0.01% |
+6,422
| New | +$289K |
|
3621
Karat Packaging
KRT
$789M
| $282K | ﹤0.01% |
+11,358
| New | +$250K |
|
3622
CALL
Insulet
PODD
$11.3B
| $282K | ﹤0.01% |
1,300
-2,600
| -67% | -$446K |
|
3623
iShares North American Natural Resources ETF
IGE
$747M
| $281K | ﹤0.01% |
+6,890
| New | +$279K |
|
3624
10x Genomics
TXG
$5.87B
| $277K | ﹤0.01% |
4,944
-55,361
| -92% | -$2.41M |
|
3625
Cosan
CSAN
$2.96B
| $276K | ﹤0.01% |
+17,625
| New | +$246K |
|
Similar funds
D.E. Shaw & Co's Q4 2023 Portfolio in Review
As of Q4 2023, D.E. Shaw & Co held 4,806 positions worth $114B, up 19% from $95.8B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
D.E. Shaw & Co's Q4 2023 filing shows 575 new, 1,549 increased, 1,464 reduced and 527 closed positions. Its largest new stake was iShares iBoxx $ High Yield Corporate Bond ETF: 2,424,593 shares worth $188M. The largest sale was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $546M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- D.E. Shaw & Co's largest Q4 2023 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 2,424,593 shares worth $188M.
- D.E. Shaw & Co added most to Netflix in Q4 2023, an estimated $751M increase.
- D.E. Shaw & Co's biggest Q4 2023 reduction was Microsoft, cutting an estimated $336M.
- D.E. Shaw & Co fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $546M.
- D.E. Shaw & Co's ten largest holdings make up 12% of its $114B portfolio in Q4 2023.
- D.E. Shaw & Co opened 575 new positions and closed 527 in Q4 2023.
- D.E. Shaw & Co's portfolio value rose 19% quarter-over-quarter to $114B.
Based on D.E. Shaw & Co's 13F filing for Q4 2023, filed 14 Feb 2024.